{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T05:33:29Z","timestamp":1738388009724,"version":"3.35.0"},"reference-count":25,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,2,1]]},"DOI":"10.2169\/internalmedicine.3484-24","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T22:12:25Z","timestamp":1720044745000},"page":"439-447","source":"Crossref","is-referenced-by-count":0,"title":["Autopsy Case of Epstein-Barr Virus-associated T-cell Post-transplant Lymphoproliferative Disorder with Mono- and Polymorphic Lesions: Possibility of 'Polymorphic T-cell Post-transplant Lymphoproliferative Disorder'"],"prefix":"10.2169","volume":"64","author":[{"given":"Keijiro","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimitsu","family":"Ueki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Tokutake","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Shigeto","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Shinshu University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kanno","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nagano Red Cross Hospital, Japan"},{"name":"Department of Pathology, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Sumi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Styczynski J, Einsele H, Gil L, Ljungman P. Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases. Transpl Infect Dis 11: 383-392, 2009.","DOI":"10.1111\/j.1399-3062.2009.00411.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Goto R, Kawamura N, Watanabe M, et al. Post-transplant indolent T cell lymphoproliferative disorder in living donor liver transplantation: a case report. Surg Case Rep 6: 147, 2020.","DOI":"10.1186\/s40792-020-00904-y"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sumi M, Satomi H, Kitahara M, et al. Clinical characteristics of posttransplant lymphoproliferative disorder after cord blood transplantation without antithymocyte globulin. Clin Lymphoma Myeloma Leuk 22: 495-503, 2022.","DOI":"10.1016\/j.clml.2021.12.015"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Abbas F, Kossi ME, Shaheen IS, Sharma A, Halawa A. Post-transplantation lymphoproliferative disorders: current concepts and future therapeutic approaches. World J Transplant 10: 29-46, 2020.","DOI":"10.5500\/wjt.v10.i2.29"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Dierickx D, Habermann TM. Post-transplantation lymphoproliferative disorders in adults. N Engl J Med 378: 549-562, 2018.","DOI":"10.1056\/NEJMra1702693"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Swerdlow SH. T-cell and NK-cell posttransplantation lymphoproliferative disorders. Am J Clin Pathol 127: 887-895, 2007.","DOI":"10.1309\/LYXN3RGF7D7KPYG0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nalesnik MA. The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach. Transpl Infect Dis 3: 88-96, 2001.","DOI":"10.1034\/j.1399-3062.2001.003002088.x"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Heslop HE. How I treat EBV lymphoproliferation. Blood 114: 4002-4008, 2009.","DOI":"10.1182\/blood-2009-07-143545"},{"key":"9","unstructured":"9. Swerdlow SH, Webber SA, Chadburn A, Ferry JA. Post-transplant lymphoproliferative disorders, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue. Revised 4th ed. Lyon, 2017."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Quintanilla-Martinez L, Swerdlow SH, Tousseyn T, Barrionuevo C, Nakamura S, Jaffe ES. New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders. Virchows Arch Int J Pathol 482: 227-244, 2023.","DOI":"10.1007\/s00428-022-03414-4"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Benhattar J, Delacretaz F, Martin P, Chaubert P, Costa J. Improved polymerase chain reaction detection of clonal T-cell lymphoid neoplasms. Diagn Mol Pathol 4: 108, 1995.","DOI":"10.1097\/00019606-199506000-00006"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Langerak AW, Groenen PJTA, Br\u00fcggemann M, et al. EuroClonality\/BIOMED-2 guidelines for interpretation and reporting of Ig\/TCR clonality testing in suspected lymphoproliferations. Leukemia 26: 2159-2171, 2012.","DOI":"10.1038\/leu.2012.246"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tiede C, Maecker-Kolhoff B, Klein C, Kreipe H, Hussein K. Risk factors and prognosis in T-cell posttransplantation lymphoproliferative diseases: reevaluation of 163 cases. Transplantation 95: 479-488, 2013.","DOI":"10.1097\/TP.0b013e3182762e07"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Herreman A, Dierickx D, Morscio J, et al. Clinicopathological characteristics of posttransplant lymphoproliferative disorders of T-cell origin: single-center series of nine cases and meta-analysis of 147 reported cases. Leuk Lymphoma 54: 2190-2199, 2013.","DOI":"10.3109\/10428194.2013.775436"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kuno M, Ito A, Maeshima AM, et al. T-cell posttransplant lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Int J Hematol 112: 193-199, 2020.","DOI":"10.1007\/s12185-020-02890-1"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tanaka T, Takizawa J, Miyakoshi S, et al. Manifestations of fulminant CD8 T-cell post-transplant lymphoproliferative disorder following the administration of rituximab for lymphadenopathy with a high level of Epstein-Barr virus (EBV) replication after allogeneic hematopoietic stem cell transplantation. Intern Med 53: 2115-2119, 2014.","DOI":"10.2169\/internalmedicine.53.2384"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Arai A. Advances in the study of chronic active Epstein-Barr virus infection: clinical features under the 2016 WHO classification and mechanisms of development. Front Pediatr 7: 14, 2019.","DOI":"10.3389\/fped.2019.00014"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ohshima K, Kimura H, Yoshino T, et al. Proposed categorization of pathological states of EBV-associated T\/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int 58: 209-217, 2008.","DOI":"10.1111\/j.1440-1827.2008.02213.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ohga S, Nomura A, Takada H, et al. Epstein-Barr virus (EBV) load and cytokine gene expression in activated T Cells of chronic active EBV infection. J Infect Dis 183: 1-7, 2001.","DOI":"10.1086\/317653"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Kimura H, Hoshino Y, Kanegane H, et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 98: 280-286, 2001.","DOI":"10.1182\/blood.V98.2.280"},{"key":"21","unstructured":"21. Murata T, Kimura H. EBV and oncogenesis. Ketsuekinaika (Hematology) 71: 181-186, 2015 (in Japanese)."},{"key":"22","unstructured":"22. Asano N. Age-related EBV associated B-cell lymphoproliferative disorders. Ketsuekinaika (Hematology) 71: 231-236, 2015 (in Japanese)."},{"key":"23","unstructured":"23. Ando M. The novel treatment strategies for EBV-associated lymphomas. Ketsuekinaika (Hematology) 81: 627-632, 2020 (in Japanese)."},{"key":"24","unstructured":"24. Oshima K. Chronic active Epstein-Barr virus infection. Hematol Oncol (Ketsueki Shuyoka) 56: 281-287, 2008 (in Japanese)."},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36: 1720-1748, 2022.","DOI":"10.1038\/s41375-022-01620-2"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/3\/64_3484-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T03:34:08Z","timestamp":1738380848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/3\/64_3484-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3484-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,2,1]]},"article-number":"3484-24"}}